Shanghai Yizhong Pharmaceutical Co., Ltd. (SHA:688091)

SHA:688091 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	191.77	44.01	649.53	914.76	710.38	110.43
Short-Term Investments	495.56	10.39	21.7	-	78.46	10.05
Trading Asset Securities	249.13	370.73	-	325.42	338.9	832.65
Cash & Short-Term Investments	936.46	425.13	671.23	1,240	1,128	953.13
Cash Growth	62.33%	-36.66%	-45.88%	9.97%	18.32%	1774.41%
Accounts Receivable	146.61	130.19	49.27	143.15	42.44	4.1
Other Receivables	9.23	5.71	0.08	-	-	9.35
Receivables	155.85	135.9	49.35	143.15	42.44	13.46
Inventory	51.89	62.5	45.17	28.41	17.06	11.78
Prepaid Expenses	5.24	1.82	2.71	0.53	1.76	3.36
Other Current Assets	12.33	5.78	7.75	0.98	10.71	11.82
Total Current Assets	1,162	631.14	776.21	1,413	1,200	993.55
Property, Plant & Equipment	292.17	274.35	149.28	120.21	121.45	83.95
Long-Term Investments	101.51	569.9	467.77	21.01	20.32	105.82
Other Intangible Assets	30.13	28.76	8.36	8.58	8.79	9.01
Long-Term Deferred Tax Assets	11.77	10.85	7.62	5.65	1.84	6.07
Long-Term Deferred Charges	6.63	6.83	8.59	1.86	0.22	-
Other Long-Term Assets	0.49	5.24	30.16	2.81	2.25	2.16
Total Assets	1,604	1,527	1,448	1,573	1,355	1,201

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	27.06	26.15	23.33	31.83	13.58	0.74
Accrued Expenses	29.96	13.99	6.34	7.56	6.08	1.62
Short-Term Debt	-	-	-	44.03	-	16.75
Current Portion of Long-Term Debt	0.01	0.01	-	-	-	-
Current Income Taxes Payable	-	-	-	10.3	-	-
Current Unearned Revenue	1.68	1.58	4.38	1.11	0.12	-
Other Current Liabilities	25.22	27.12	5.39	9.16	10.08	2
Total Current Liabilities	83.93	68.85	39.45	103.98	29.86	21.1
Long-Term Debt	25	25	-	-	-	-
Long-Term Unearned Revenue	2.68	0.6	1.03	1.47	2.29	3.13
Long-Term Deferred Tax Liabilities	2.24	2.3	2.5	3.07	3.26	0.79
Total Liabilities	113.85	96.75	42.97	108.52	35.42	25.02

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	206.7	206.7	206.59	158.28	143.89	105.8
Additional Paid-In Capital	1,046	1,039	1,043	1,072	1,059	1,096
Retained Earnings	299.45	257.15	192.59	234.68	116.29	-26.56
Treasury Stock	-61.28	-72.24	-37.24	-	-	-
Shareholders' Equity	1,491	1,430	1,405	1,465	1,319	1,176
Total Liabilities & Equity	1,604	1,527	1,448	1,573	1,355	1,201

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	25.01	25.01	-	44.03	-	16.75
Net Cash (Debt)	911.45	400.12	671.23	1,196	1,128	936.38
Net Cash Growth	57.99%	-40.39%	-43.88%	6.07%	20.44%	1867.20%
Net Cash Per Share	4.51	1.98	2.89	7.55	5.47	6.02
Filing Date Shares Outstanding	221.17	204.8	205.31	205.76	205.76	205.76
Total Common Shares Outstanding	221.17	204.8	205.31	205.76	205.76	205.76
Working Capital	1,078	562.29	736.76	1,309	1,170	972.45
Book Value Per Share	6.74	6.98	6.84	7.12	6.41	5.71
Tangible Book Value	1,460	1,402	1,397	1,456	1,310	1,167
Tangible Book Value Per Share	6.60	6.84	6.80	7.08	6.37	5.67
Buildings	80.55	80.55	80.55	80.55	80.55	80.55
Machinery	102.77	101.14	81.55	76.29	35.23	29.38
Construction In Progress	178.94	156.51	39.49	4.81	39.44	1.58

Data Source: S&P Global Market Intelligence Last updated: Aug 25, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 2, 2026

Data Sources Report a data error